VIAL
Compound comparison

Cortagen vs Sermorelin

Cortagen and Sermorelin are both peptide compounds evaluated on Vial: Cortagen is not FDA approved for human use with preclinical evidence, and Sermorelin is available as a compounded preparation with clinical-trial evidence.

Vial summary · compiled from public records

At a glance

Cortagen

Category
Peptide
FDA / legal status
Gray Market
Route
0providers on Vial →

Sermorelin

Category
Peptide
FDA / legal status
Compoundable
Route
Subcutaneous
27providers on Vial →

Side by side

FieldCortagenSermorelin
CategoryPeptidePeptide
Brand names
FDA / legal statusGray MarketCompoundable
Evidence tierPreclinicalClinical Trials
Administration routeSubcutaneous
Compounding accessNot FDA approved, limited regulated accessAvailable through 503A and 503B compounding pharmacies
Providers on Vial0 listed27 listed
Typical price bandVaries by provider$ to $$$

Verified providers offering each

Ranked by Confidence Rating, Vial’s 0 to 100 score built from federal and state public records. The score evaluates the provider, not the compound.

85+ High Confidence70 to 84 Well Documented50 to 69 Limited ConfidenceUnder 50 Flagged

About each compound

About Cortagen

Cortagen is a synthetic tetrapeptide bioregulator (Ala-Glu-Asp-Pro) targeting brain cortex function, developed by the St. Petersburg Institute of Bioregulation. Russian research suggests it improves cognitive function, stress resilience, and neurological recovery in aging populations. It is part of the same peptide bioregulator family as epitalon, vilon, and pinealon, designed to restore tissue-specific gene expression patterns.

About Sermorelin

A synthetic analog of growth hormone-releasing hormone (GHRH), this 29-amino acid peptide stimulates the pituitary gland to produce and secrete endogenous growth hormone through binding to GHRH receptors. It functions by mimicking the N-terminal bioactive portion of native GHRH, promoting pulsatile GH release while preserving the body's natural feedback mechanisms. Primary applications include diagnostic testing of pituitary function and therapeutic use in growth hormone deficiency.

Descriptions compiled from public FDA records and manufacturer labeling where available. Not medical advice.

This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.

Related compound comparisons

Other comparisons in the same category.

All compound comparisons →